Remove tag start-ups
article thumbnail

Biogen, Eisai Alzheimer’s drug lecanemab fast tracked by FDA

pharmaphorum

Biogen and Eisai head towards the end of the year with some much-needed good news in their Alzheimer’s programmes, as the FDA awards a fast-track designation to lecanemab, their follow-up to recently approved Aduhelm.

FDA 111
article thumbnail

The best SingleCare reviews of 2023

The Checkup by Singlecare

The start of a new year provides an opportunity to refresh and renew—to turn your attention to neglected areas of life. If there’s a drug you need to take, but you can’t swing the steep price tag, ask your pharmacist to check SingleCare’s prices. Show your pharmacist the coupon to start saving.

Insurance 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: Pharmalittle: Some employers cut insurance coverage for weight loss drugs; U.S. urges ADHD pill makers to boost production

STAT

So grab that cup of stimulation — our flavor today boasts the aroma of bananas — and get started. Medicare and Medicaid patients will make up 92% of the market for the drug, called Leqembi. Besides the $26,500 annual price tag, treatment could cost U.S. And what better way to make the time fly than to keep busy.

article thumbnail

Axsome bounces back as FDA clears depression drug

pharmaphorum

Shares in Axsome Therapeutics have rocketed on FDA approval of its depression therapy Auvelity (formerly AXS-05) – a year after its approval was held up by the regulator. Auvelity is the first drug Axsome has taken through to regulatory approval, but could be the first of a string of new products for the company, according to Tabuteau.

FDA 98
article thumbnail

Biogen’s Aduhelm rollout goes from bad to worse

pharmaphorum

Analysts were predicting sales of Biogen’s recently approved Alzheimer’s therapy Aduhelm may start to gather a little momentum in the third quarter, but the drug seems to be going into reverse. Vounatsos also insisted that Aduhelm’s price tag has not been a factor discouraging treatment with the drug.

Insurance 120
article thumbnail

What can pharma marketing learn from other regulated industries?

pharmaphorum

In this article Joanna Carlish, managing director of financial services at Tag Americas , and Robb DeFilippis, Tag Americas’ managing director, life sciences, go head-to-head to discuss marketing within a regulated industry. Sales calls that now have to start with a phone call are supported by digital and social content straightaway.

article thumbnail

Leverage Marketing Technology To Level Up Your Pharmacy Growth

DiversifyRx

But now, our email list has grown so much that I can not keep up, and I want to maintain these relationships. THE BEGINNER CRM If you’re beginning your pharmacy marketing or have just pivoted from a freelancer or an outside marketing company, CONVERT KIT would be a great CRM to start with. It’s easy to set up.

52